Slimerix – Semaglutide Research Peptide Pen (5mg / 3ml)
All products are shipped in a cooler box at the appropriate temperature.
What is Semaglutide?
Semaglutide is a highly potent, long-acting synthetic analog of the human GLP-1 (glucagon-like peptide-1) hormone — a key regulator of glucose metabolism, appetite, and energy balance. Engineered with targeted structural modifications that confer exceptional stability and an extended half-life of approximately 7 days, semaglutide has become one of the most widely studied compounds in modern metabolic research.
Slimerix delivers premium-grade semaglutide (>99% purity, third-party verified) in a convenient, ready-to-use pre-filled pen format, purpose-built for laboratory and research applications investigating GLP-1 receptor signaling, appetite regulation, glucose homeostasis, and body weight modulation.
What are the benefits of Semaglutide in research?
As a GLP-1 receptor agonist, semaglutide engages a broad range of physiological pathways, making it a highly versatile compound for metabolic research. Key areas of investigational interest include:
- Insulin secretion & glucagon suppression: Semaglutide stimulates glucose-dependent insulin release from the pancreas while suppressing glucagon, supporting improved glycemic control in research models.
- Appetite regulation: Acting through both central and peripheral mechanisms, semaglutide consistently demonstrates significant reductions in appetite and overall food intake across study models.
- Gastric emptying: The compound delays gastric emptying, prolonging satiety signaling and reducing postprandial glucose excursions — a well-documented effect in GLP-1 receptor agonist research.
- Body weight modulation: Semaglutide research has produced some of the most compelling weight reduction data in the incretin class, with substantial reductions in total body weight consistently observed across clinical and preclinical models.
- Energy balance: Investigations have documented favorable modulation of energy homeostasis, with semaglutide influencing both caloric intake and metabolic efficiency.
- Cardiometabolic parameters: Research findings have shown positive shifts in lipid profiles, inflammatory markers, blood pressure, and overall cardiovascular risk indicators in subjects receiving semaglutide.
- Liver health: Semaglutide has demonstrated improvements in hepatic fat accumulation and liver function markers, making it a subject of growing interest in fatty liver disease research.
Clinical Research & Trial Results
Semaglutide has undergone extensive clinical investigation, with landmark trials consistently confirming its efficacy and safety profile. In the SUSTAIN 6 trial — one of the most significant semaglutide cardiovascular outcome studies — data from over 3,000 participants with type 2 diabetes demonstrated a meaningful reduction in the risk of major cardiac events and stroke.
Further clinical studies have validated semaglutide’s effects on blood glucose reduction, insulin secretion, glycemic control, and body weight regulation. The totality of the clinical evidence places semaglutide among the most comprehensively studied and consistently effective compounds in GLP-1 receptor agonist research. Its approximately 7-day half-life, achieved through advanced structural engineering, supports once-weekly dosing schedules across a wide range of research protocols.
Proper Usage & Dosage Guidelines
The dosage and administration of semaglutide for research purposes should be determined in accordance with the specific experimental protocol in use. Slimerix is administered via subcutaneous injection, with semaglutide’s extended half-life of approximately 7 days supporting once-weekly administration in research settings.
Pen Specifications – Slimerix 5mg / 3ml Pen:
The Slimerix pen contains 5mg of semaglutide in 3ml solution, providing flexible dosing possibilities for a wide range of in-vitro and in-vivo experimental protocols.
Dosage Reference:
- 1 unit = 25 mcg
- 10 units = 0.25 mg
- 20 units = 0.50 mg
- 30 units = 0.75 mg
- 40 units = 1.00 mg
Additional Usage Notes:
- Inject into the abdomen area or the front of the thigh
- After injecting, wait 10 seconds before removing the needle
- Rotate injection sites between administrations
- Store refrigerated at all times; do not freeze
- Use sterile, single-use needles only — replace with each injection
Possible Side Effects
Consistent with the broader GLP-1 receptor agonist class, semaglutide research has identified a well-characterized side effect profile. The most commonly observed effects include nausea, vomiting, diarrhea, constipation, and mild discomfort or itching at the injection site. These effects are most frequently reported during initial dosing or dose escalation phases and typically resolve as administration continues.
Adherence to established dosing protocols remains the most reliable approach to minimizing adverse responses in research settings.
What’s Included
- Reusable precision peptide pen injector
- Pre-filled Slimerix (semaglutide) solution — 5mg / 3ml
- Detailed usage instructions
- 10 sterile, single-use needles
Why Choose Slimerix?
Slimerix is produced in certified laboratories to deliver semaglutide at greater than 99% purity, independently verified by third-party testing. The ready-to-use pre-filled pen format offers a sterile, precise, and lab-friendly experience designed for researchers who require consistency, reliability, and ease of use. The 5mg / 3ml format provides ample flexibility across a broad spectrum of dosing requirements and experimental designs.
Explore cutting-edge GLP-1 receptor research with Slimerix — precision, potency, and convenience in one advanced research tool.
The information presented has been collected from published studies and analyses and is not intended for diagnosing, treating, or preventing any disease.
Notice: Slimerix (semaglutide) is sold strictly for in-vitro laboratory research and scientific investigation only. It is not a drug, not intended for human consumption, medical treatment, or therapeutic use of any kind. Not for use in humans or animals. The purchaser assumes full responsibility for proper handling, storage, and compliance with all applicable local laws and regulations.
Reviews
There are no reviews yet.